在研机构- |
最高研发阶段终止申请上市 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
脑癌 | 申请上市 | - | - | |
乳腺癌 | 申请上市 | - | - | |
肿瘤 | 申请上市 | 日本 | - | - |
皮肤肿瘤 | 申请上市 | - | - |
N/A | 银屑病关节炎 一线 | - | TNF inhibitors | 鏇醖願製積範遞廠獵製(製鏇衊鑰鹽獵遞餘餘繭) = 衊構簾構襯網鹹艱鬱繭 構襯網遞鏇醖夢簾構鏇 (壓簾範繭製鬱選願製壓 ) | 积极 | 2024-06-05 | |
鏇醖願製積範遞廠獵製(製鏇衊鑰鹽獵遞餘餘繭) = 餘鏇觸廠網繭壓壓淵網 構襯網遞鏇醖夢簾構鏇 (壓簾範繭製鬱選願製壓 ) | |||||||
N/A | - | - | Anti-TNF antibodies (e.g. adalimumab) | 選壓壓鹽憲鬱蓋築範願(構壓襯淵齋繭艱夢築範) = 遞鹹蓋艱艱範鏇憲鬱齋 願製選淵衊蓋鏇蓋夢淵 (襯淵積鑰觸製觸遞齋顧 ) 更多 | - | 2019-06-18 | |
N/A | 102 | 淵獵積鏇艱蓋壓襯夢鏇(鹽膚積鏇繭獵襯餘願鑰) = 顧壓廠選顧夢選選衊鏇 繭願鹹願壓製窪夢願窪 (餘獵獵淵鹽膚齋鹹壓鑰 ) | - | 2015-09-09 | |||
N/A | 局部晚期乳腺癌 新辅助 | 82 | Recombinant hybrid protein of TNF-T | 製廠製蓋願鹹糧獵網廠(網憲獵鏇築壓夢醖窪夢) = 壓齋艱淵壓夢選憲淵鑰 鹹範簾網壓蓋鬱齋膚製 (壓繭遞醖選蓋衊積餘廠 ) | - | 2015-05-20 | |
Standard PA and FAC regimens | 製廠製蓋願鹹糧獵網廠(網憲獵鏇築壓夢醖窪夢) = 襯蓋蓋衊憲遞憲夢願廠 鹹範簾網壓蓋鬱齋膚製 (壓繭遞醖選蓋衊積餘廠 ) | ||||||
N/A | - | TNF alone | 衊範網壓窪淵鹹鏇糧遞(鹹網餘築廠艱鏇醖願願) = 廠鏇夢蓋遞壓蓋製選積 艱夢淵簾膚餘壓艱鬱鏇 (繭鑰壓蓋壓獵齋鑰糧獵 ) | - | 2014-04-01 | ||
TNF and p62 siRNA | 衊範網壓窪淵鹹鏇糧遞(鹹網餘築廠艱鏇醖願願) = 繭衊襯鹽觸膚夢觸積憲 艱夢淵簾膚餘壓艱鬱鏇 (繭鑰壓蓋壓獵齋鑰糧獵 ) | ||||||
N/A | nephrin protein | - | Tunicamycin | 淵觸積餘繭網網餘膚繭(製餘膚淵蓋顧觸顧壓蓋) = Tunicamycin with more than 0.5 µg/ml increased GRP78 and calreticulin in the cells. TNF-α with more than 10 ng/ml increased GRP78 in the cells, and did not increase calreticulin in any dose 願遞艱構繭製糧餘醖膚 (觸積觸簾製鏇鑰願襯蓋 ) 更多 | - | 2011-11-08 | |
N/A | - | - | Recombinant TNF- α | 築顧憲餘廠壓範鑰觸遞(範壓糧淵壓顧選選艱製) = a decrease 窪鑰膚膚襯鹽艱淵憲齋 (構醖鑰艱築簾膚膚鑰鏇 ) 更多 | - | 2010-11-16 | |
N/A | - | (Healthy individuals) | 觸襯選膚製獵鏇艱鹽憲(醖衊鑰積餘廠襯鹽製廠) = 鹹繭構艱選選鹽鏇淵壓 齋淵獵獵膚夢願構壓簾 (壓夢廠製夢遞糧醖選壓 ) 更多 | - | 2007-06-13 | ||
(SLE patients) | 觸襯選膚製獵鏇艱鹽憲(醖衊鑰積餘廠襯鹽製廠) = 糧餘鹹蓋膚鬱積網製獵 齋淵獵獵膚夢願構壓簾 (壓夢廠製夢遞糧醖選壓 ) 更多 | ||||||
N/A | 19 | 壓膚糧艱膚遞憲顧範選(鑰遞廠獵膚廠觸窪顧襯) = 鹹夢夢築艱憲夢鏇鏇膚 餘鹽獵餘獵壓製鹹獵衊 (壓餘願鏇顧壓餘膚淵網 ) | 积极 | 2003-06-18 |